Bristol-Myers Squibb Company Ce logo

Bristol-Myers Squibb Company Ce (CELG-RI)

Market Closed
3 Jun, 20:00
NYSE NYSE
$
0. 1098
+0.0086
+8.5%
$
212.22M Market Cap
- P/E Ratio
- Div Yield
9,118 Volume
- Eps
$ 0.1012
Previous Close
Investors:
Add Transaction
Day Range
0.1049 0.1399
Year Range
0.1049 0.1399
Want to track CELG-RI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

CELG-RI closed today higher at $0.11, an increase of 8.5% from yesterday's close, completing a monthly decrease of -4.85% or -$0.01. Over the past 12 months, CELG-RI stock gained 52.5%.
CELG-RI is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

CELG-RI Chart

People also search for

American Well Corporation
$ 8.46
-0.47%
Owlet Inc.
$ 4.95
-5.71%

Bristol-Myers Squibb Company Ce Investors

Name Quantity Cost Value Profit ($) Gain (%)
MC
Matthew Cochran Atlantic Edge Private Wealth Management, LLC
16 $0.88 $1.76 $0.88 99.64%
PCA
Purkiss Capital Advisors LLC Purkiss Capital Advisors LLC
26,450 $1,296 $2,909.5 $1,608.21 124.09%

Bristol-Myers Squibb Company Ce (CELG-RI) FAQ

What is the stock price today?

The current price is $0.1098.

On which exchange is it traded?

Bristol-Myers Squibb Company Ce is listed on NYSE.

What is its stock symbol?

The ticker symbol is CELG-RI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 212.22M.

Has Bristol-Myers Squibb Company Ce ever had a stock split?

No, there has never been a stock split.

Bristol-Myers Squibb Company Ce Profile

Pharmaceuticals Industry
Healthcare Sector
Christopher S. Boerner CEO
NYSE Exchange
110122140 CUSIP
US Country
34,100 Employees
- Last Dividend
- Last Split
- IPO Date
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Contact Information

Address: Route 206 & Province Line Road
Phone: +1 609 252 4000